1.A New (2Fe-2S) Ferredoxin Gene from Trichomonas Vaginalis
Yucai FU ; Hong XU ; Jiaxin ZHANG ; Kehao ZHNAG ; Hong LIU ; Huirong LIN ; Xiaohong ZHENG
Journal of Tropical Medicine 2004;4(4):352-356,381
Objectives The ferredoxins are iron-sulfur proteins, which function in electron transfer reactions in a variety of systems and participate in the activation of the antimicrobial agent metronidazole. The aim of this study is to clone and characterize ferredoxin genes of Trichomonas vaginalis. Methods A cDNA expression library was constructed with T. Vaginalis total RNA. Hundreds of cDNA clones were isolated and sequenced. Sequence analysis was performed using BLAST programs, ClustalW program, etc. Results One of the cDNA clones, which has homology with T.vaginalis ferredoxin, was further analyzed. This cDNA clone has an open reading frame of 312 base pairs. The deduced precursor protein contains 103 amino acid residues with a hydrogenosome targeting sequence (MLSQCSPLRF) at the N-terminal end. The primary sequence analysis revealed that this new ferredoxin (TvFd2) has a high homology (69% identity) to the previous reported T.vaginalis ferredoxin(TvFd). Interestingly, TvFd2 is homologous to both the two subclasses of (2Fe-2S) ferredoxins, the oxidase ferredoxins and the photosynthetic ferredoxins,but with low similarity. The conserved four-cysteine residues, which are predicted to form the iron-sulfur cluster,are arranged in a typical pattern of (2Fe-2S)ferredoxins(-C-X5-C-X2-C-Xn-C-). Conclusion These data show that TvFd2 is a putative new (2Fe-2S) ferredoxin of T.vaginalis. Its biological function remains to be studied.
2.A case report of HLRCC syndrome combined Ⅳ inferior vena cava tumor thrombus
Kehao LI ; Yuancheng DU ; Xueping ZHANG ; Changqing LIU ; Li GE ; Yongxiang LI ; Liang QIAO
Chinese Journal of Urology 2021;42(10):782-783
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a rare hereditary disease and characterized by cutaneous leiomyoma, uterine leiomyoma and/or renal cell carcinoma, but rarely associated with vena cava embolism. We treated 1 case of HLRCC syndrome patients with inferior vena cava tumor emboli (Mayo grade Ⅳ), confirmed after genetic testing, the patient and her family refused further treatment. The patient died after two months of follow-up after discharge.
3.Development history and prospects of disease control informatization in Hubei
Jing CAI ; Kehao LIU ; Feilong XIAO ; Ran WU ; Mingyan LI
Journal of Public Health and Preventive Medicine 2020;32(3):16-19
Objective To sort out the development history of disease control informatization in Hubei, and provide reference for the establishment of the "Hubei model" of disease control informatization. Methods To understand the development process through data access and site investigation. Result Hubei CDC has built a provincial and municipal two-level data center; built a full-coverage security network; built a full traceable immune planning system; built a provincial, city, and county three-level video conference system; established a professional disease Control the information team. Conclusion The "Hubei model" of disease control informationization has a solid foundation. It will adhere to the development concept of people as the core, business as the problem-oriented, big data as the means, multi-point trigger as the benchmark, and network security as the foundation. Play the role of technical support and information leadership in the control business.